{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:28:10Z","timestamp":1793287690280,"version":"4.5.0"},"reference-count":28,"publisher":"XMLink","issue":"4","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Corcept Therapeutics, Inc.","id":[{"id":"https:\/\/ror.org\/03ey3qt70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["ejgo.org"],"crossmark-restriction":false},"short-container-title":["J Gynecol Oncol"],"DOI":"10.3802\/jgo.2024.35.e111","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T02:20:42Z","timestamp":1719800442000},"update-policy":"https:\/\/doi.org\/10.3802\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer"],"prefix":"10.3802","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-9255","authenticated-orcid":false,"given":"Alexander B.","family":"Olawaiye","sequence":"first","affiliation":[{"name":"University of Pittsburgh School of Medicine and Magee-Womens Hospital, Gynecologic Oncology Group, Pittsburgh, PA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1835-9436","authenticated-orcid":false,"given":"Jae-Weon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Seoul National University, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5519-2598","authenticated-orcid":false,"given":"Andrea","family":"Bagameri","sequence":"additional","affiliation":[{"name":"National Institute of Oncology, Budapest, Hungary."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-4754","authenticated-orcid":false,"given":"Erin","family":"Bishop","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Gynecologic Oncology Group, Milwaukee, WI, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-7968","authenticated-orcid":false,"given":"Anita","family":"Chudecka-G\u0142az","sequence":"additional","affiliation":[{"name":"Pomeranian Medical University, Polish Gynecologic Oncology Group, Szczecin, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0320-1850","authenticated-orcid":false,"given":"Alix","family":"Devaux","sequence":"additional","affiliation":[{"name":"Oncology Department of Grand H\u00f4pital de Charleroi, Charleroi, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-9719","authenticated-orcid":false,"given":"Laurence","family":"Gladieff","sequence":"additional","affiliation":[{"name":"Institut Claudius Regaud-Institut Universitaire du Cancer de Toulouse Oncopole, Groupe d\u2019Investigateurs Nationaux pour l\u2019Etude des Cancers Ovariens, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4242-6520","authenticated-orcid":false,"given":"Mary E.","family":"Gordinier","sequence":"additional","affiliation":[{"name":"Norton Cancer Institute, Louisville, KY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-4582","authenticated-orcid":false,"given":"Jacob","family":"Korach","sequence":"additional","affiliation":[{"name":"Sheba Medical Center, School of Medicine, Tel Aviv University, Israeli Society of Gynecologic Oncology, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3010-3537","authenticated-orcid":false,"given":"Michael E.","family":"McCollum","sequence":"additional","affiliation":[{"name":"Virginia Oncology Associates, Norfolk, VA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6826-6014","authenticated-orcid":false,"given":"Linda","family":"Mileshkin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-0159","authenticated-orcid":false,"given":"Bradley J.","family":"Monk","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Group Foundation; Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-405X","authenticated-orcid":false,"given":"Shibani","family":"Nicum","sequence":"additional","affiliation":[{"name":"University College London Cancer Institute, National Cancer Research Institute, London, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-8310","authenticated-orcid":false,"given":"Ang\u00e9lica","family":"Nogueira-Rodrigues","sequence":"additional","affiliation":[{"name":"Federal University of Minas Gerais, Dom Oncologia and Oncoclinicas - Brazil, Belo Horizonte, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-7194","authenticated-orcid":false,"given":"Ana","family":"Oaknin","sequence":"additional","affiliation":[{"name":"Medical Oncology Service, Vall d\u2019Hebron Institute of Oncology, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2828-0177","authenticated-orcid":false,"given":"David M.","family":"O\u2019Malley","sequence":"additional","affiliation":[{"name":"The Ohio State University and the James Cancer Center, Gynecologic Oncology Group, Columbus, OH, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5428-0394","authenticated-orcid":false,"given":"Mauro","family":"Orlando","sequence":"additional","affiliation":[{"name":"Instituto Alexander Fleming, Buenos Aires, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0134-733X","authenticated-orcid":false,"given":"Lyndah","family":"Dreiling","sequence":"additional","affiliation":[{"name":"Corcept Therapeutics Incorporated, Menlo Park, CA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4229-2940","authenticated-orcid":false,"given":"Iulia C.","family":"Tudor","sequence":"additional","affiliation":[{"name":"Corcept Therapeutics Incorporated, Menlo Park, CA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-0598","authenticated-orcid":false,"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico and Catholic University of the Sacred Heart, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","published-online":{"date-parts":[[2024]]},"reference":[{"key":"10.3802\/jgo.2024.35.e111_ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.3802\/jgo.2024.35.e111_ref2","first-page":"937","volume":"93","author":"Doubeni","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.3802\/jgo.2024.35.e111_ref3","unstructured":"National Cancer Institute. SEER cancer stat facts: ovarian cancer [Internet]. Bethesda, MD. National Cancer Institute. 2023. cited 2024 Feb 23. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html"},{"key":"10.3802\/jgo.2024.35.e111_ref4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.3802\/jgo.2024.35.e111_ref5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/ijms24031973","volume":"24","author":"Atallah","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.3802\/jgo.2024.35.e111_ref6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","volume":"137","author":"Kurnit","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.3802\/jgo.2024.35.e111_ref7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/medicina59030544","volume":"59","author":"Havasi","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.3802\/jgo.2024.35.e111_ref8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","volume":"34","author":"Gonz\u00e1lez-Mart\u00edn","year":"2023","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref10","volume-title":"Elahere [package insert]","author":"ImmunoGen, Inc","year":"2024"},{"key":"10.3802\/jgo.2024.35.e111_ref11","doi-asserted-by":"crossref","first-page":"1258228","DOI":"10.3389\/fonc.2023.1258228","volume":"13","author":"Eskander","year":"2023","journal-title":"Front Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref12","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-21-4363","volume":"28","author":"Munster","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.3802\/jgo.2024.35.e111_ref13","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1200\/JCO.22.02624","volume":"41","author":"Colombo","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref14","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-12-3826","volume":"19","author":"Skor","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.3802\/jgo.2024.35.e111_ref15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.18632\/oncotarget.27989","volume":"12","author":"Greenstein","year":"2021","journal-title":"Oncotarget"},{"key":"10.3802\/jgo.2024.35.e111_ref16","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1200\/JCO.23.01195","volume":"41","author":"Prekovic","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2017.04.012","volume":"146","author":"Veneris","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ygyno.2015.06.033","volume":"138","author":"Stringer-Reasor","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/ERC-21-0048","volume":"28","author":"Greenstein","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"10.3802\/jgo.2024.35.e111_ref20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.3802\/jgo.2024.35.e111_ref21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.3802\/jgo.2024.35.e111_ref22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jcph.1731","volume":"61","author":"Custodio","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.3802\/jgo.2024.35.e111_ref23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3390\/ijms25031845","volume":"25","author":"Tavares","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.3802\/jgo.2024.35.e111_ref24","unstructured":"NovoCure Ltd. Effect of tumor treating fields (TTFields, 200 kHz) concomitant with weekly paclitaxel for the treatment of recurrent ovarian cancer (ENGOT-ov50\/GOG-3029\/INNOVATE-3) [Internet]. Bethesda, MD. National Library of Medicine. 2024. cited 2024 Apr 11. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03940196"},{"key":"10.3802\/jgo.2024.35.e111_ref25","unstructured":"US Food and Drug Administration. FDA grants accelerated approval to mirvetuximab soravtansine-gynx for FR\u03b1 positive, platinum-resistant epithelial ovarian, fallopian tube, or peritoneal cancer [Internet]. Silver Spring, MD. US Food and Drug Administration. 2022. cited 2024 Feb 13. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-mirvetuximab-soravtansine-gynx-fra-positive-platinum-resistant"},{"key":"10.3802\/jgo.2024.35.e111_ref26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaoncol.2023.0197","volume":"9","author":"Richardson","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.3802\/jgo.2024.35.e111_ref27","doi-asserted-by":"crossref","first-page":"101155","DOI":"10.1016\/j.gore.2023.101155","volume":"47","author":"Hendershot","year":"2023","journal-title":"Gynecol Oncol Rep"},{"key":"10.3802\/jgo.2024.35.e111_ref28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/ijgc-2023-004924","volume":"34","author":"Bogani","year":"2024","journal-title":"Int J Gynecol Cancer"}],"container-title":["Journal of Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ejgo.org\/pdf\/10.3802\/jgo.2024.35.e111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2024.35.e111","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2024.35.e111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T22:55:45Z","timestamp":1721084145000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejgo.org\/DOIx.php?id=10.3802\/jgo.2024.35.e111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3802\/jgo.2024.35.e111","relation":{},"ISSN":["2005-0380","2005-0399"],"issn-type":[{"value":"2005-0380","type":"print"},{"value":"2005-0399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"2024-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-26","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2024. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}],"article-number":"e111"}}